(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

ST13

US500000076168438

Class

16, 42

Filing

76168438

Registration

2590911

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

01/12/2023

Trademark type

Word

Nice classes

16, 42

Filing date

11/20/2000

Registration date

07/09/2002

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/12/2023

Last transaction

01/12/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1977-00-00

First use in commerce

1977-00-00

Drawing code

1

Owner type

03

Owner location

London, GB

Examiner

MAYERSCHOFF, GLENN

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

INFORMA UK LIMITED
TAYLOR & FRANCIS GROUP, LLC
TAYLOR & FRANICS BOOKS, INC.
Marcel Dekker, Inc.

Representatives

William C. Wright Epstein Drangel LLP

Technical classification

Nice Classes

Class 16Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

printed publicationsjournals concerning both technological and organizational aspects of industrial pharmacyall aspects of the development and production of drugs and pharmaceutical products

Class 42

computer servicesproviding on-linevia the internetjournals concerning both technological and organizational aspects of industrial pharmacyall aspects of the development and production of drugs and pharmaceutical products

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/12/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

01/12/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/12/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/12/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

06/28/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/09/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/09/2015

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/09/2015

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/30/2012

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/30/2012

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/30/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/29/2012

E89R

TEAS SECTION 8 & 9 RECEIVED

08/08/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/29/2009

PLGL

ASSIGNED TO PARALEGAL

01/13/2009

E815

TEAS SECTION 8 & 15 RECEIVED

01/08/2009

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/24/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/10/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/10/2008

CFIT

CASE FILE IN TICRS

10/17/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2005

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2005

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/09/2004

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2002

PUBO

PUBLISHED FOR OPPOSITION

04/16/2002

NPUB

NOTICE OF PUBLICATION

03/27/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/21/2001

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/21/2001

CNRT

NON-FINAL ACTION MAILED

05/22/2001

DOCK

ASSIGNED TO EXAMINER

05/14/2001

Continuous trademark protection

Get notified about every new filing that threatens DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.